Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in Avantor, Inc. (NYSE:AVTR – Free Report) by 13.1% in the 4th quarter, HoldingsChannel reports. The fund owned 507,188 shares of the company’s stock after acquiring an additional 58,671 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Avantor were worth $11,036,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB grew its position in shares of Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after purchasing an additional 625 shares during the period. Smartleaf Asset Management LLC grew its holdings in Avantor by 106.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after buying an additional 830 shares during the period. Global Retirement Partners LLC increased its stake in shares of Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after acquiring an additional 1,067 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after acquiring an additional 1,074 shares during the period. Finally, AlphaQuest LLC acquired a new stake in shares of Avantor in the fourth quarter worth approximately $65,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Insiders Place Their Bets
In other news, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. The trade was a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by company insiders.
Analyst Ratings Changes
View Our Latest Research Report on Avantor
Avantor Stock Performance
Avantor stock opened at $16.24 on Tuesday. Avantor, Inc. has a 12-month low of $15.37 and a 12-month high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The company has a market capitalization of $11.05 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The firm’s fifty day moving average price is $18.28 and its 200 day moving average price is $21.28.
Avantor (NYSE:AVTR – Get Free Report) last announced its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter last year, the business earned $0.22 EPS. On average, research analysts forecast that Avantor, Inc. will post 1.06 EPS for the current fiscal year.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- Stock Market Upgrades: What Are They?
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Growth Stocks: What They Are, What They Are Not
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.